Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Nature Medicine Publishes Results from an Investigator-Initiated Trial of CARsgen's CT041 Claudin18.2 CAR T Cells in Gastrointestinal Cancers 2022-05-10 20:50
Bora Pharmaceuticals acquires Eden Biologics CDMO Assets 2022-05-10 17:53
AffaMed Therapeutics Holds DEXTENZA Launch and Advisory Board Meeting in Macau 2022-05-10 09:00
iNtRON Biotechnology, Inc., Launches New Website 2022-05-09 21:00
OBiO Technology to Present Data on OVersatile™ Platform for Process Development of Herpes Simplex Virus and Vaccinia Virus Products at the 25th ASGCT Annual Meeting 2022-05-09 19:40
Series A financing round lays foundation for international growth of digital cancer therapeutics Mika 2022-05-09 19:35
AskGene Limited Announces Completion of USD 20 Million Series A Financing Led by Qiming Venture Partners and TF Capital 2022-05-09 11:37
JW Therapeutics to Present Latest Data of Carteyva® at 2022 ASCO Annual Meeting 2022-05-09 09:00
JW Therapeutics to Present Latest Data of Carteyva® at 2022 ASCO Annual Meeting 2022-05-09 09:00
InxMed Raised $15 million in Series B+ Financing to Advance Innovative Therapies to Drug-resistant Cancers 2022-05-09 08:04
Brii Bio Reports Progress on ESG Commitments in Its Inaugural ESG Report 2022-05-07 09:00
Aravax appoints Dr Brett Haumann to Board of Directors 2022-05-06 21:00
Antengene to Participate in Three Upcoming Investor Conferences in May/June 2022-05-06 08:30
Harbour BioMed Appoints Dr. Alexander A. Zukiwski to its Scientific Advisory Board 2022-05-06 08:00
Insilico Medicine expands synthetic lethality portfolio with the nomination of a preclinical candidate targeting MAT2A for the treatment of MTAP-deleted cancers 2022-05-06 05:00
Insilico Medicine expands synthetic lethality portfolio with nomination of a preclinical candidate targeting MAT2A for the treatment of MTAP-deleted cancers 2022-05-05 23:00
HOYA Vision Care Releases Results of First of its Kind Six-Year MiYOSMART Spectacle Lens Follow-up Clinical Study 2022-05-05 22:12
TIKOMED and IQVIA announce a strategic collaboration for the development of TIKOMED's lead drug platform candidate ILB® 2022-05-05 20:40
Mediso acquires nuclear medicine supplier Bartec Technologies 2022-05-05 06:38
Kintor Pharma Announces First Patient Dosing in Multi-Regional Global Phase II Clinical Trial of ALK-1 Antibody and Nivolumab Combination Therapy for the Treatment of Advanced Hepatocellular Carcinoma 2022-05-04 20:36
1 177 178 179 180 181 452